Treace Medical Concepts, Inc. is a medical technology company. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It also has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of the midfoot as well as its Hammertoe PEEK Fixation System designed to address hammertoe, claw toe and mallet toe deformities. The Lapiplasty, Adductoplasty and Hammertoe PEEK Fixation Systems are comprised of single-use implant kits and reusable instrument trays. The Company sells these products to physicians, surgeons, hospitals and ambulatory surgery centers in the United States.
企業コードTMCI
会社名Treace Medical Concepts Inc
上場日Apr 23, 2021
最高経営責任者「CEO」Mr. John T. Treace
従業員数477
証券種類Ordinary Share
決算期末Apr 23
本社所在地100 Palmetto Park Place
都市PONTE VEDRA
証券取引所NASDAQ Global Select Consolidated
国United States of America
郵便番号32081
電話番号19043735940
ウェブサイトhttps://www.treace.com/
企業コードTMCI
上場日Apr 23, 2021
最高経営責任者「CEO」Mr. John T. Treace
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし